InsideTrading SEC Form 4 insider trades
← All clusters
BBIO

BridgeBio Pharma, Inc.

Healthcare Pharmaceutical Preparations Market cap: $15.3B Ticker page → Watch BBIO (just your e-mail) Price alert (just your e-mail)

Moderate buying: $2.4M bought (counted up to $5.0M); 7 distinct insiders. Holding it back: largest buyer: MOMTAZEE JAMES C (Director), 49% of the dollars.

63
Insider ScoreThe number from 0 to 100 shown on each cluster and used to rank the lists. By default it is the match score, plus the points of the AI review when there is one. It describes the buying; it is not a forecast or a recommendation. 60–79 · moderate buying
+312.4%
Since the cluster formed, vs benchmark (+380.7% raw)

Score, not a recommendation.

Total bought$2.4M14 Form 4 purchases
Distinct insiders7open-market buyers
Insiders' average price$14.33+446.4% to the latest close
Cluster window2021-12-28 → 2022-01-05closed

Price and insider purchases

Live chart from Yahoo Finance, loaded through this server; our daily closes when it is unavailable.

Loading price history…

How the score adds up

How each input is counted →
Points each input adds to the score, and how much of the points it could give it has
Input Strength Points
$2.4M bought (counted up to $5.0M)The dollars the insiders bought, a purchase reported jointly counted once, counted from $131. Each tenfold adds 12.4 points, up to $5.0M; more adds nothing. The bar is empty at $10.0K and full at $5.0M. 88% +53
7 distinct insidersHow many different insiders bought. Each extra insider adds less than the one before (the points follow the log of the count: 4.3 per doubling). The bar is full at 10 insiders. 85% +12
No CEO among the buyersWhether the chief executive is among the buyers: 10.6 points when yes. 0% +0
Stock 84% below its 1-year high (counted up to 30%)How far the stock had fallen from its highest close of the past year, at the close before the buying. Every 10% of fall adds 1.9 points. A fall beyond 30% adds nothing more. The bar is full at a 30% fall. 100% +5
8 days from first to last purchaseDays between the first and the last purchase. Each day takes off 0.11 points: buying close together keeps more. The bar is empty at 60 days. 87% -1
Routine or plan purchases: 0% of the dollarsThe share of the dollars in routine or plan purchases (a Rule 10b5-1 plan, dividend reinvestment, a regular cadence). All of it routine would take off 5.6 points. 100% +0
Largest buyer: MOMTAZEE JAMES C (Director), 49% of the dollarsThe share of the dollars bought by the largest buyer. Buying spread evenly keeps the points; one buyer paying for everything takes off 12.7. 59% -6
Match scoreA score from 0 to 100 worked out from the dollars bought, the number of insiders, whether a CEO bought, how far the stock had fallen, how spread out the purchases were and how much came from one buyer. Its weights were calibrated on past clusters. It is the default ranking of the lists and it decides which clusters get the AI review. It describes the buying; it is not a forecast.63

Why are they buying?

No explanation has been generated for this cluster. The filings in the table below are the primary evidence.

Transactions

14 Form 4 trades · 7 insiders Download CSV Up to 5,000 rows
Purchases in this cluster, grouped by insider, largest first
Date InsiderAn officer or director of a company, or an owner of more than 10% of its shares. The law requires them to report their trades in the company's stock to the SEC. Role Shares Price Value Filing
2021-12-29 MOMTAZEE JAMES C history of MOMTAZEE JAMES C's purchases Director 80,000 $14.50 $1.2M SEC filing for MOMTAZEE JAMES C (opens in a new tab)
2021-12-28 → 2021-12-30 DANIELS RONALD J history of DANIELS RONALD J's purchases Director 22,147 $13.49 avg $298.7K
2021-12-28 DANIELS RONALD J 11,745 $12.73 $149.5K SEC filing for DANIELS RONALD J (opens in a new tab)
2021-12-30 DANIELS RONALD J 10,402 $14.34 $149.2K SEC filing for DANIELS RONALD J (opens in a new tab)
2021-12-29 Hassan Fred history of Hassan Fred's purchases Director 19,300 $14.17 $273.5K SEC filing for Hassan Fred (opens in a new tab)
2021-12-29 SAUNDERS BRENT L history of SAUNDERS BRENT L's purchases Director 17,600 $14.48 $254.8K SEC filing for SAUNDERS BRENT L (opens in a new tab)
2022-01-04 → 2022-01-05 Dachille Douglas A. history of Dachille Douglas A.'s purchases Director 10,000 $16.36 avg $163.6K
2022-01-04 Dachille Douglas A. 5,000 $16.82 $84.1K SEC filing for Dachille Douglas A. (opens in a new tab)
2022-01-05 Dachille Douglas A. 5,000 $15.91 $79.6K SEC filing for Dachille Douglas A. (opens in a new tab)
2021-12-28 → 2021-12-29 Valantine Hannah 4 purchases with a 63-day result · median -3.7% Director 7,745 $13.56 avg $105.0K
2021-12-28 Valantine Hannah 1,891 $13.18 $24.9K SEC filing for Valantine Hannah (opens in a new tab)
2021-12-28 Valantine Hannah 1,542 $12.68 $19.6K SEC filing for Valantine Hannah (opens in a new tab)
2021-12-28 Valantine Hannah 796 $13.16 $10.5K SEC filing for Valantine Hannah (opens in a new tab)
2021-12-29 Valantine Hannah 1,764 $14.23 $25.1K SEC filing for Valantine Hannah (opens in a new tab)
2021-12-29 Valantine Hannah 1,752 $14.24 $24.9K SEC filing for Valantine Hannah (opens in a new tab)
2021-12-29 → 2021-12-30 Lo Andrew history of Lo Andrew's purchases Director 7,500 $13.18 avg $98.8K
2021-12-29 Lo Andrew 6,000 $12.90 $77.4K SEC filing for Lo Andrew (opens in a new tab)
2021-12-30 Lo Andrew 1,500 $14.30 $21.4K SEC filing for Lo Andrew (opens in a new tab)
Total $2.4M

Other buying runs at BBIO

A buying runPurchases at one company with no pause longer than the cluster rule allows. A long pause ends the run, so one company can have several. ends after a pause in the buying, so one company can have several. Returns are the stock's return minus its benchmarkThe index a stock's return is compared with: a small-cap index for small companies, a large-cap index otherwise. (IWM for small companies, SPY otherwise), from the first open after the buying run became a cluster. Past results, not a forecast.

After this buying run became a cluster, vs benchmark: 21 days -30.7% (-43.3% raw)63 days -20.0% (-30.0% raw)126 days -17.2% (-39.2% raw)

Other insider buying runs at this company, newest first, with the return against the benchmark that followed
Window Insiders Total Score 21 days vs benchmark63 days vs benchmark126 days vs benchmark Status
2019-06-27 → 2019-07-01 5 $126.3M 44 -1.4% (-6.0% raw)-30.4% (-31.4% raw)+11.4% (+21.0% raw) closed